Monograph
A10BD05 - Metformin and Pioglitazone |
Propably not porphyrinogenic |
PNP |
Rationale
This combination product contains two substances: metformin (ATC code: A10B A02) and pioglitazone (ATC code: A10B G03). Metformin is safety classified as Not porphyrinogenic (NP) while pioglitazone is safety classified as Probably not porphyrinogenic (PNP). The classification of the combination is according to the most porphyrinogenic of the two substances. For more details please refer to the monographs of the two substances.
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Competact 15 mg/850 mg, tabletten 
Competact 15 mg - 850 mg compr. pellic. 
Competact 15 mg/850 mg Comprimidos Recubiertos con Pelicula · GLUBRAVA 15 mg/850 mg COMPRIMIDOS RECUBIERTOS CON PELICULA · Pioglitazona/Metformina Aristo 15 mg/850 mg Comprimidos Recubiertos con Pelicula efg 
Competact · Metformin / Pioglitazone 
Competact · Metformin / Pioglitazone 
Competact 
Competact 
Competact · Glubrava 
Competact 
Competact 
Competact 
Competact
© NAPOS 2025